Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin versus placebo in adults with HIV infection starting antiretroviral therapy
PACTR202003522049711Phase 2Suspended
- Sponsor
- Muhimbili University of Health and Allied Sciences
- Start
- Feb 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of aspirin in human immunodeficiency virus infection (HIV), sponsored by Muhimbili University of Health and Allied Sciences. Primary endpoint: Virological response. Started Feb 2020; status: suspended.
02
Drugs
aspirin
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on PACTR202003522049711.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202003522049711.